223 related articles for article (PubMed ID: 17513315)
1. Misleading promotion of drugs in Bangladesh: evidence from drug promotional brochures distributed to general practitioners by the pharmaceutical companies.
Islam MS; Farah SS
J Public Health (Oxf); 2007 Jun; 29(2):212-3. PubMed ID: 17513315
[No Abstract] [Full Text] [Related]
2. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
Cardarelli R; Licciardone JC; Taylor LG
BMC Fam Pract; 2006 Mar; 7():13. PubMed ID: 16515686
[TBL] [Abstract][Full Text] [Related]
4. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
Civaner M
Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
[TBL] [Abstract][Full Text] [Related]
5. Exposing nursing students to the marketing methods of pharmaceutical companies.
Civaner M; Sarikaya O; Alici SU; Bozkurt G
Nurs Ethics; 2008 May; 15(3):396-410. PubMed ID: 18388173
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical advertising versus research spending: are profits more important than patients?
Mukherjee D; Topol EJ
Am Heart J; 2003 Oct; 146(4):563-4. PubMed ID: 14564305
[No Abstract] [Full Text] [Related]
7. Attitudes of general practitioners to their interactions with pharmaceutical companies: a qualitative study.
Quinn RJ; O'Neill C
Ir Med J; 2002; 95(7):199-202. PubMed ID: 12227525
[TBL] [Abstract][Full Text] [Related]
8. Misleading drug promotion--no sign of improvements.
Mansfield PR; Henry D
Pharmacoepidemiol Drug Saf; 2004 Nov; 13(11):797-9. PubMed ID: 15386716
[No Abstract] [Full Text] [Related]
9. Promotional literature: how do we critically appraise?
Shetty VV; Karve AV
J Postgrad Med; 2008; 54(3):217-21. PubMed ID: 18626173
[TBL] [Abstract][Full Text] [Related]
10. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
Castresana L; Mejia R; Aznar M
Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
[TBL] [Abstract][Full Text] [Related]
11. [Printed material distributed by pharmaceutical propaganda agents].
Mejía R; Avalos A
Medicina (B Aires); 2001; 61(3):315-8. PubMed ID: 11474880
[TBL] [Abstract][Full Text] [Related]
12. The use of generic or patent medicines in the Netherlands.
Gebhardt DO
J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361
[No Abstract] [Full Text] [Related]
13. Drug company influence.
Mittman D
Am J Nurs; 2009 Mar; 109(3):14; author reply 14. PubMed ID: 19240469
[No Abstract] [Full Text] [Related]
14. The ethics of advertising strategies in the pharmaceutical industry.
Reuter L
Ethics Med; 2003; 19(3):171-5. PubMed ID: 14700051
[No Abstract] [Full Text] [Related]
15. Why physician's sample? Else they are trade promotional material!
Agarwal RK
J Indian Med Assoc; 2008 Aug; 106(8):543. PubMed ID: 18979615
[No Abstract] [Full Text] [Related]
16. Pharma PR or medical education?
Oldani MJ
Hastings Cent Rep; 2005; 35(2):6-7. PubMed ID: 15957307
[No Abstract] [Full Text] [Related]
17. [Caution for false advertising].
Heinzl S
Med Monatsschr Pharm; 2003 Feb; 26(2):37. PubMed ID: 12619521
[No Abstract] [Full Text] [Related]
18. The influence of pharmaceutical companies.
Messmer JJ
J Fam Pract; 2000 Dec; 49(12):1154; author reply 1155. PubMed ID: 11132069
[No Abstract] [Full Text] [Related]
19. The influence of pharmaceutical companies.
Parnes B
J Fam Pract; 2000 Dec; 49(12):1154-5. PubMed ID: 11132068
[No Abstract] [Full Text] [Related]
20. No more pens: what the 2009 Pharmaceutical Research and Manufacturer's Association code changes really mean.
Meffert JJ
Clin Dermatol; 2009; 27(4):346-9. PubMed ID: 19539160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
